top of page

NIDA: Reported Drug Use Among Adolescents Continued to Hold Below Pre-pandemic Levels in 2023

December 20, 2023

The percentage of adolescents reporting they used any illicit substances in 2023 continued to hold steady below the pre-pandemic levels reported in 2020 according to a survey funded by the National Institute on Drug Abuse.

Telehealth Supports Retention in Treatment for Opioid Use Disorder

October 30, 2023

A study of Medicaid data in Kentucky and Ohio from 2019-2020 showed evidence that staring buprenorphine treatment for opioid use disorder through telehealth was associated with an increased likelihood of staying in treatment longer compared to starting treatment in a non-telehealth setting.


March 18-24, 2024 

National Drug and Alcohol Facts Week 

National Drug and Alcohol Facts Week is an annual health observance that inspires dialogue about the science of drug use and addiction among youth. This annual observance provides an opportunity to bring together scientists, students, educators, healthcare providers, and community partners to help advance the science and address youth drug and alcohol use in communities and nationwide.

May 12-18, 2024

National Prevention Week

National Prevention Week is a public education platform showcasing the work of communities and organizations that are preventing substance use and misuse and promoting positive mental health. The SAMHSA website provides information on ways to get involved, promotional materials, an events planning tool kit, and a way to submit your ideas and plans for events and activities in your community.


DEA collected more than 599,897 pounds of unwanted or unneeded medications during the October 28, 2023 National Prescription Drug Take Back Day.

Pharmaceutical fentanyl is a synthetic opioid, approved for treating severe pain, typically advanced cancer pain. It is 50-100 times more potent than morphine. Most recent cases of fentanyl-related harm, overdose, and death in the U.S. are linked to illegally made fentanyl. 

Governor Gordan's office hosts an educational webinar series addressing issues important to Wyoming's behavioral health system.

The Wyoming Department of Health and the Wyoming Survey & Analysis Center's Prescription Drug Abuse Prevention Toolkit is a resource for stakeholders engaged in prevention efforts. 

Get Involved

In 2008, prescription drug overdose deaths in Wyoming were at an unprecedented and dramatic all-time high. The alarming number of deaths were impacting people of all walks of life, in every corner of our state. Unlike many other “street drugs” like methamphetamine & cocaine, prescription drug abuse was destroying and taking lives. Law enforcement, health officials, and many others were trying to understand the cause and how best to combat this emerging crisis. In response, a handful of stakeholders decided it was time to bring together the best expertise possible to help address this significant public health and safety issue. Since 2008, the Wyoming Rx Abuse Stakeholders (RAS) members from across Wyoming have gathered to discuss the origin & scope of the problem, prevention measures and solutions, education strategies, and tools and resources to curb this serious problem. Today, with the assistance of many people throughout the State, the RAS task force diligently continues their effort to protect the people of Wyoming from the real dangers of prescription medication abuse and misuse.


If you would like information about the RAS or are interested in joining the task force, please click the link below to contact us.

bottom of page